Martin M, Lim E, Chavez-MacGregor M, Bardia A, et al. Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. J Clin Oncol 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500.
PMID: 38537155